blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3190121

EP3190121 - METHODS FOR STEREOSELECTIVE REDUCTION OF CYCLOPAMINE 4-EN-3-ONE DERIVATIVE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  27.12.2019
Database last updated on 13.11.2024
FormerThe patent has been granted
Status updated on  18.01.2019
FormerGrant of patent is intended
Status updated on  01.07.2018
FormerRequest for examination was made
Status updated on  19.01.2018
FormerThe application has been published
Status updated on  15.06.2017
Most recent event   Tooltip23.07.2021Lapse of the patent in a contracting state
New state(s): MT		published on 25.08.2021  [2021/34]
Applicant(s)For all designated states
Infinity Pharmaceuticals, Inc.
780 Memorial Drive
Cambridge, MA 02139 / US
[2017/28]
Inventor(s)01 / Austad, Brian C.
170 Mitchell G. Drive
Tewksbury, Massachusetts 01876 / US
02 / Lescarbeau, Andre
33 Mecham Road
Somerville, Massachusetts 02144 / US
03 / Yu, Lin-Chen
5 Union Street
Quincy, Massachusetts 02169 / US
 [2019/08]
Former [2017/28]01 / Austad, Brian C.
170 Mitchell G. Drive
Tewksbury, MA Massachusetts 01876 / US
02 / Lescarbeau, Andre
33 Mecham Road
Somerville, MA Massachusetts 02144 / US
03 / Yu, Lin-Chen
5 Union Street
Quincy, MA Massachusetts 02169 / US
Representative(s)V.O.
P.O. Box 87930
Carnegieplein 5
2508 DH Den Haag / NL
[2017/28]
Application number, filing date16197797.024.12.2008
[2017/28]
Priority number, dateUS20070017162P27.12.2007         Original published format: US 17162 P
US2007096568827.12.2007         Original published format: US 965688
[2017/28]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3190121
Date:12.07.2017
Language:EN
[2017/28]
Type: B1 Patent specification 
No.:EP3190121
Date:20.02.2019
Language:EN
[2019/08]
Search report(s)(Supplementary) European search report - dispatched on:EP22.05.2017
ClassificationIPC:A61K31/00, A61K31/282, A61K31/337, A61K31/4355, A61K31/7068, A61K33/24, A61K45/06, A61P35/00, A61P35/02, C07J63/00, C07J71/00, // C07J1/00, C07J21/00, C07J43/00, C07J5/00, C07J65/00, C07J7/00, C07J9/00, C07J69/00
[2018/29]
CPC:
C07J71/0005 (EP,US); C07J7/009 (US); A61P35/00 (EP);
A61P35/02 (EP); C07D471/10 (EP,US); C07D491/22 (EP,US);
C07J63/00 (EP,US); C07B2200/09 (US); C07J1/0011 (EP,US);
C07J21/00 (EP,US); C07J43/006 (EP,US); C07J5/0053 (EP,US);
C07J65/00 (EP,US); C07J69/00 (EP,US); C07J9/00 (EP,US) (-)
Former IPC [2017/28]C07F15/04, C07D221/18, A61K31/00, A61K31/282, A61K31/337, A61K31/4355, A61K31/7068, A61K33/24, A61K45/06, A61P35/00, A61P35/02, C07J63/00, // C07D471/10
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2018/08]
Former [2017/28]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:VERFAHREN ZUR STEREOSELEKTIVEN REDUKTION VON CYCLOPAMIN 4-EN-3-ON DERIVAT[2017/28]
English:METHODS FOR STEREOSELECTIVE REDUCTION OF CYCLOPAMINE 4-EN-3-ONE DERIVATIVE[2017/28]
French:PROCÉDÉS DE RÉDUCTION STÉRÉO-SÉLECTIVE DU DERIVÉ 4-EN-3-ONE DE CYCLOPAMINE[2017/28]
Examination procedure08.11.2016Date on which the examining division has become responsible
12.01.2018Amendment by applicant (claims and/or description)
12.01.2018Examination requested  [2018/08]
02.07.2018Communication of intention to grant the patent
31.10.2018Fee for grant paid
31.10.2018Fee for publishing/printing paid
31.10.2018Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP08868213.3  / EP2224807
Opposition(s)21.11.2019No opposition filed within time limit [2020/05]
Fees paidRenewal fee
23.02.2017Renewal fee patent year 03
23.02.2017Renewal fee patent year 04
23.02.2017Renewal fee patent year 05
23.02.2017Renewal fee patent year 06
23.02.2017Renewal fee patent year 07
23.02.2017Renewal fee patent year 08
27.12.2016Renewal fee patent year 09
27.12.2017Renewal fee patent year 10
31.12.2018Renewal fee patent year 11
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU24.12.2008
AT20.02.2019
CY20.02.2019
CZ20.02.2019
DK20.02.2019
EE20.02.2019
FI20.02.2019
HR20.02.2019
LT20.02.2019
LV20.02.2019
MC20.02.2019
MT20.02.2019
NL20.02.2019
PL20.02.2019
RO20.02.2019
SE20.02.2019
SI20.02.2019
SK20.02.2019
TR20.02.2019
BG20.05.2019
NO20.05.2019
GR21.05.2019
IS20.06.2019
PT20.06.2019
[2021/34]
Former [2021/32]HU24.12.2008
AT20.02.2019
CY20.02.2019
CZ20.02.2019
DK20.02.2019
EE20.02.2019
FI20.02.2019
HR20.02.2019
LT20.02.2019
LV20.02.2019
MC20.02.2019
NL20.02.2019
PL20.02.2019
RO20.02.2019
SE20.02.2019
SI20.02.2019
SK20.02.2019
TR20.02.2019
BG20.05.2019
NO20.05.2019
GR21.05.2019
IS20.06.2019
PT20.06.2019
Former [2021/26]AT20.02.2019
CY20.02.2019
CZ20.02.2019
DK20.02.2019
EE20.02.2019
FI20.02.2019
HR20.02.2019
LT20.02.2019
LV20.02.2019
MC20.02.2019
NL20.02.2019
PL20.02.2019
RO20.02.2019
SE20.02.2019
SI20.02.2019
SK20.02.2019
TR20.02.2019
BG20.05.2019
NO20.05.2019
GR21.05.2019
IS20.06.2019
PT20.06.2019
Former [2020/39]AT20.02.2019
CZ20.02.2019
DK20.02.2019
EE20.02.2019
FI20.02.2019
HR20.02.2019
LT20.02.2019
LV20.02.2019
MC20.02.2019
NL20.02.2019
PL20.02.2019
RO20.02.2019
SE20.02.2019
SI20.02.2019
SK20.02.2019
TR20.02.2019
BG20.05.2019
NO20.05.2019
GR21.05.2019
IS20.06.2019
PT20.06.2019
Former [2020/17]AT20.02.2019
CZ20.02.2019
DK20.02.2019
EE20.02.2019
FI20.02.2019
HR20.02.2019
LT20.02.2019
LV20.02.2019
NL20.02.2019
PL20.02.2019
RO20.02.2019
SE20.02.2019
SI20.02.2019
SK20.02.2019
TR20.02.2019
BG20.05.2019
NO20.05.2019
GR21.05.2019
IS20.06.2019
PT20.06.2019
Former [2020/13]AT20.02.2019
CZ20.02.2019
DK20.02.2019
EE20.02.2019
FI20.02.2019
HR20.02.2019
LT20.02.2019
LV20.02.2019
NL20.02.2019
PL20.02.2019
RO20.02.2019
SE20.02.2019
SI20.02.2019
SK20.02.2019
BG20.05.2019
NO20.05.2019
GR21.05.2019
IS20.06.2019
PT20.06.2019
Former [2020/03]AT20.02.2019
CZ20.02.2019
DK20.02.2019
EE20.02.2019
FI20.02.2019
HR20.02.2019
LT20.02.2019
LV20.02.2019
NL20.02.2019
PL20.02.2019
RO20.02.2019
SE20.02.2019
SK20.02.2019
BG20.05.2019
NO20.05.2019
GR21.05.2019
IS20.06.2019
PT20.06.2019
Former [2020/01]CZ20.02.2019
DK20.02.2019
EE20.02.2019
FI20.02.2019
HR20.02.2019
LT20.02.2019
LV20.02.2019
NL20.02.2019
PL20.02.2019
RO20.02.2019
SE20.02.2019
SK20.02.2019
BG20.05.2019
NO20.05.2019
GR21.05.2019
IS20.06.2019
PT20.06.2019
Former [2019/49]CZ20.02.2019
DK20.02.2019
EE20.02.2019
FI20.02.2019
HR20.02.2019
LT20.02.2019
LV20.02.2019
NL20.02.2019
RO20.02.2019
SE20.02.2019
SK20.02.2019
BG20.05.2019
NO20.05.2019
GR21.05.2019
IS20.06.2019
PT20.06.2019
Former [2019/48]DK20.02.2019
FI20.02.2019
HR20.02.2019
LT20.02.2019
LV20.02.2019
NL20.02.2019
SE20.02.2019
BG20.05.2019
NO20.05.2019
GR21.05.2019
IS20.06.2019
PT20.06.2019
Former [2019/39]FI20.02.2019
HR20.02.2019
LT20.02.2019
LV20.02.2019
NL20.02.2019
SE20.02.2019
BG20.05.2019
NO20.05.2019
GR21.05.2019
IS20.06.2019
PT20.06.2019
Former [2019/38]FI20.02.2019
LT20.02.2019
SE20.02.2019
BG20.05.2019
NO20.05.2019
GR21.05.2019
PT20.06.2019
Former [2019/37]FI20.02.2019
LT20.02.2019
SE20.02.2019
NO20.05.2019
GR21.05.2019
PT20.06.2019
Former [2019/34]FI20.02.2019
LT20.02.2019
SE20.02.2019
NO20.05.2019
PT20.06.2019
Former [2019/33]FI20.02.2019
LT20.02.2019
NO20.05.2019
PT20.06.2019
Documents cited:Search[XPI]WO2008083248  (INFINITY DISCOVERY INC [US], et al) [XP] 1 * page 62, paragraph [0150]; example 24 *[I] 1-3;
 [I]  - MASAMUNE TADASHI ET AL, "Synthesis and nuclear magnetic resonance spectra of 22,27-imino-17,23-epoxyjervane derivatives", TETRAHEDRON, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, (19670101), vol. 23, no. 4, doi:10.1016/S0040-4020(01)82558-8, ISSN 0040-4020, pages 1591 - 1612, XP002166405 [I] 1-3 * page 1607, paragraph l *

DOI:   http://dx.doi.org/10.1016/S0040-4020(01)82558-8
by applicant   - MARCH, ADVANCED ORGANIC CHEMISTRY
    - GREENE, PROTECTIVE GROUPS IN ORGANIC SYNTHESIS
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.